These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
443 related items for PubMed ID: 11908926
1. Remission induction therapy for childhood acute lymphoblastic leukaemia: clinical and cellular pharmacology of vincristine, corticosteroids, L-asparaginase and anthracyclines. Ronghe M, Burke GA, Lowis SP, Estlin EJ. Cancer Treat Rev; 2001 Dec; 27(6):327-37. PubMed ID: 11908926 [Abstract] [Full Text] [Related]
10. Resistance to glucocorticoids in childhood acute lymphoblastic leukemia: impact of relationship between ex vivo sensitivity and in vivo concentration on risk factor analysis. Styczynski J, Koltan A, Wysocki M. Neoplasma; 2006 Feb; 53(2):168-73. PubMed ID: 16575474 [Abstract] [Full Text] [Related]
11. Long-term results of the AIEOP-ALL-95 Trial for Childhood Acute Lymphoblastic Leukemia: insight on the prognostic value of DNA index in the framework of Berlin-Frankfurt-Muenster based chemotherapy. Aricò M, Valsecchi MG, Rizzari C, Barisone E, Biondi A, Casale F, Locatelli F, Lo Nigro L, Luciani M, Messina C, Micalizzi C, Parasole R, Pession A, Santoro N, Testi AM, Silvestri D, Basso G, Masera G, Conter V. J Clin Oncol; 2008 Jan 10; 26(2):283-9. PubMed ID: 18182669 [Abstract] [Full Text] [Related]
13. Expression levels of TEL, AML1, and the fusion products TEL-AML1 and AML1-TEL versus drug sensitivity and clinical outcome in t(12;21)-positive pediatric acute lymphoblastic leukemia. Stams WA, den Boer ML, Beverloo HB, Meijerink JP, van Wering ER, Janka-Schaub GE, Pieters R. Clin Cancer Res; 2005 Apr 15; 11(8):2974-80. PubMed ID: 15837750 [Abstract] [Full Text] [Related]
15. Long-term results of a randomized trial on extended use of high dose L-asparaginase for standard risk childhood acute lymphoblastic leukemia. Pession A, Valsecchi MG, Masera G, Kamps WA, Magyarosy E, Rizzari C, van Wering ER, Lo Nigro L, van der Does A, Locatelli F, Basso G, Aricò M. J Clin Oncol; 2005 Oct 01; 23(28):7161-7. PubMed ID: 16192600 [Abstract] [Full Text] [Related]
16. The role of pharmacokinetic and pharmacodynamic studies in the planning of protocols for the treatment of childhood cancer. Burke GA, Estlin EJ, Lowis SP. Cancer Treat Rev; 1999 Feb 01; 25(1):13-27. PubMed ID: 10212587 [Abstract] [Full Text] [Related]
17. Use of L-asparaginase in childhood ALL. Müller HJ, Boos J. Crit Rev Oncol Hematol; 1998 Aug 01; 28(2):97-113. PubMed ID: 9768345 [Abstract] [Full Text] [Related]